News

Immunetune is proud to have been selected as a finalist for the 2020 RESI Innovation Challenge! We will be presenting on the 23rd of March 2020 at the RESI 2020 Europe Conference in Paris.

Immunetune is proud to have been selected as one of the Top 25 of the 2020 Blue Tulip Awards in the category Health! Click here for more information.

CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam. Update March 12. Unfortunately, but fully...

Immunetune is proud to have been selected as a finalist for the 2020 RESI Innovation Challenge! We will be presenting on the 23rd of March 2020 at the RESI 2020 Europe Conference in Paris.

Immunetune is proud to have been selected as one of the Top 25 of the 2020 Blue Tulip Awards in the category Health! Click here for more information.

CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam. Update March 12. Unfortunately, but fully...

Immunetune was featured in the December 2019 issue of Biotech News & Life Science, read the full article here (in Dutch only).